Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Risk Management (New York, N.Y.)
|
August 6, 1992
Expert systems for risk management
M Jablonowski
The EMBO Journal
|
April 22, 2015
Dampening DNA damage checkpoint signalling via coordinated BRCT domain interactions
José R Cussiol, Carolyn M Jablonowski, Askar Yimit, et al.
Genetics
|
September 13, 2015
Termination of Replication Stress Signaling via Concerted Action of the Slx4 Scaffold and the PP4 Phosphatase
Carolyn M Jablonowski, José R Cussiol, Susannah Oberly, et al.
Journal of Pediatric Surgery
|
January 3, 2025
Characterizing Sensitivity to Vincristine, Irinotecan, and Telomerase-targeted Therapy in Diffuse Anaplastic Wilms Tumor Patient-derived Xenografts<sup>☆</sup>
Daniel B Gehle, Carolyn M Jablonowski, Prahalathan Pichavaram, et al.
Elife
|
February 1, 2021
Surprising phenotypic diversity of cancer-associated mutations of Gly 34 in the histone H3 tail
Brandon R Lowe, Rajesh K Yadav, Ryan A Henry, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 31, 2021
Protective T cell receptor identification for orthotopic reprogramming of immunity in refractory virus infections
Tanja A Stief, Theresa Kaeuferle, Thomas R Müller, et al.
Molecular Cancer Therapeutics
|
November 21, 2023
Oncogenic Cells of Renal Embryonic Lineage Sensitive to the Small-Molecule Inhibitor QC6352 Display Depletion of KDM4 Levels and Disruption of Ribosome Biogenesis
Prahalathan Pichavaram, Carolyn M Jablonowski, Jie Fang, et al.
Elife
|
July 19, 2017
Histone H3G34R mutation causes replication stress, homologous recombination defects and genomic instability in <i>S. pombe</i>
Rajesh K Yadav, Carolyn M Jablonowski, Alfonso G Fernandez, et al.
Elife
|
March 15, 2024
Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing associated with therapeutic response to splicing inhibitor
Carolyn M Jablonowski, Waise Quarni, Shivendra Singh, et al.
Cancers
|
April 12, 2022
<i>TERT</i> Expression in Wilms Tumor Is Regulated by Promoter Mutation or Hypermethylation, WT1, and N-MYC
Carolyn M Jablonowski, Hyea Jin Gil, Emilia M Pinto, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Risk Management (New York, N.Y.)
|
August 6, 1992
Expert systems for risk management
M Jablonowski
The EMBO Journal
|
April 22, 2015
Dampening DNA damage checkpoint signalling via coordinated BRCT domain interactions
José R Cussiol, Carolyn M Jablonowski, Askar Yimit, et al.
Genetics
|
September 13, 2015
Termination of Replication Stress Signaling via Concerted Action of the Slx4 Scaffold and the PP4 Phosphatase
Carolyn M Jablonowski, José R Cussiol, Susannah Oberly, et al.
Journal of Pediatric Surgery
|
January 3, 2025
Characterizing Sensitivity to Vincristine, Irinotecan, and Telomerase-targeted Therapy in Diffuse Anaplastic Wilms Tumor Patient-derived Xenografts<sup>☆</sup>
Daniel B Gehle, Carolyn M Jablonowski, Prahalathan Pichavaram, et al.
Elife
|
February 1, 2021
Surprising phenotypic diversity of cancer-associated mutations of Gly 34 in the histone H3 tail
Brandon R Lowe, Rajesh K Yadav, Ryan A Henry, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 31, 2021
Protective T cell receptor identification for orthotopic reprogramming of immunity in refractory virus infections
Tanja A Stief, Theresa Kaeuferle, Thomas R Müller, et al.
Molecular Cancer Therapeutics
|
November 21, 2023
Oncogenic Cells of Renal Embryonic Lineage Sensitive to the Small-Molecule Inhibitor QC6352 Display Depletion of KDM4 Levels and Disruption of Ribosome Biogenesis
Prahalathan Pichavaram, Carolyn M Jablonowski, Jie Fang, et al.
Elife
|
July 19, 2017
Histone H3G34R mutation causes replication stress, homologous recombination defects and genomic instability in <i>S. pombe</i>
Rajesh K Yadav, Carolyn M Jablonowski, Alfonso G Fernandez, et al.
Elife
|
March 15, 2024
Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing associated with therapeutic response to splicing inhibitor
Carolyn M Jablonowski, Waise Quarni, Shivendra Singh, et al.
Cancers
|
April 12, 2022
<i>TERT</i> Expression in Wilms Tumor Is Regulated by Promoter Mutation or Hypermethylation, WT1, and N-MYC
Carolyn M Jablonowski, Hyea Jin Gil, Emilia M Pinto, et al.
Page
of 2